From the First Department of Internal Medicine (Y.H., S.S., H.M., G.K.)
and the Department of Clinical Laboratory Medicine (T.O., Y.N., M.K.),
Hiroshima University School of Medicine, Japan.
Correspondence to Yukihito Higashi, MD, PhD, First Department of Internal Medicine, Hiroshima University School of Medicine, 12-3 Kasumi, Minami-ku, Hiroshima 734, Japan. E-mail yhigashi{at}mcai.med.hiroshima-u.ac.jp
AbstractEndothelial
function has been shown to be impaired in patients with essential
hypertension. The purpose of the present study was to determine
whether antihypertensive drug therapy improves impaired
endothelium-dependent renal vasorelaxation in essential
hypertensive patients without atherosclerosis. We
evaluated the effects of intravenous infusion of
L-arginine (500 mg/kg given over 30 minutes) on systemic
and renal hemodynamics in 27 patients with mild to
moderate essential hypertension who were randomly assigned to treatment
with either the angiotensin-converting enzyme
inhibitor imidapril or the calcium antagonist
amlodipine for 12 weeks in a double-blind fashion. After the 12 weeks,
the decrease in blood pressure was similar in the imidapril (n=14) and
amlodipine (n=13) groups. The increase in renal plasma flow was also
similar in both groups. L-Arginineinduced renovascular
relaxation was increased by imidapril (renal plasma flow, 9.6±5.1% to
14.4±7.4%; renal vascular resistance, -10.4±8.1% to -16.7±9.2%,
P<0.05, respectively) but not by amlodipine. Urinary
excretion of nitrite/nitrate in response to L-arginine was
significantly increased by imidapril (90±29% to 134±63%,
P<0.05) but remained unchanged by amlodipine. These
findings suggest that angiotensin-converting enzyme
inhibition improves the impaired endothelium-dependent
renovascular relaxation in patients with essential hypertension due to
the increase in nitric oxide production and that the reduction
in blood pressure with a calcium antagonist does not play a
major role in the potentiation of L-arginine/nitric
oxidemediated effects.
© 1998 American Heart Association, Inc.
Scientific Contributions
Angiotensin-Converting Enzyme Inhibition, But Not Calcium Antagonism, Improves a Response of the Renal Vasculature to L-Arginine in Patients With Essential Hypertension
Key Words: angiotensin-converting enzyme inhibitor calcium antagonist nitric oxide endothelium kidney hypertension, essential
This article has been cited by other articles:
![]() |
N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Tousoulis, C Xenakis, C Tentolouris, G Davies, C Antoniades, T Crake, and C Stefanadis Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina Heart, October 1, 2005; 91(10): 1319 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sasaki, H. M. Siragy, J. J. Gildea, R. A. Felder, and R. M. Carey Production and Role of Extracellular Guanosine Cyclic 3', 5' Monophosphate in Sodium Uptake in Human Proximal Tubule Cells Hypertension, February 1, 2004; 43(2): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kirima, K. Tsuchiya, H. Sei, T. Hasegawa, M. Shikishima, Y. Motobayashi, K. Morita, M. Yoshizumi, and T. Tamaki Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H589 - H596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Delles, M. P. Schneider, S. Oehmer, E. H. Fleischmann, and R. E. Schmieder L-Arginine-Induced Vasodilation of the Renal Vasculature Is Not Altered in Hypertensive Patients With Type 2 Diabetes Diabetes Care, June 1, 2003; 26(6): 1836 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Friedman, C. Ritter, J. C. F. Moreira, F. Dal-Pizzol, M. G. Ziegler, X. Bao, R. Matz, Y. Higashi, K. Chayama, and M. Yoshizumi Renovascular Hypertension, Endothelial Function, and Oxidative Stress N. Engl. J. Med., November 7, 2002; 347(19): 1528 - 1530. [Full Text] [PDF] |
||||
![]() |
S. Wassmann, S. Hilgers, U. Laufs, M. Bohm, and G. Nickenig Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1208 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Elung-Jensen, J. Heisterberg, A.-L. Kamper, J. Sonne, S. Strandgaard, and N. E. Larsen High serum enalaprilat in chronic renal failure Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 240 - 245. [Abstract] [PDF] |
||||
![]() |
K. A. EARLE, S. MEHROTRA, R. N. DALTON, E. DENVER, and R. SWAMINATHAN Defective Nitric Oxide Production and Functional Renal Reserve in Patients with Type 2 Diabetes Who Have Microalbuminuria of African and Asian Compared with White Origin J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2125 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, G. Kajiyama, and T. Oshima Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function J. Am. Coll. Cardiol., March 1, 2001; 37(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study J. Am. Coll. Cardiol., February 1, 2000; 35(2): 284 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, S. Kurisu, A. Yoshimizu, N. Sasaki, H. Matsuura, G. Kajiyama, and T. Oshima Regular Aerobic Exercise Augments Endothelium-Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects : Role of Endothelium-Derived Nitric Oxide Circulation, September 14, 1999; 100(11): 1194 - 1202. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |